These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37133482)

  • 1. Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
    Nahm W; Nichols A; Rapoport E; Kirsner R; Badiavas E; Wyant W; Arthur A; Shen J
    J Drugs Dermatol; 2023 May; 22(5):486-490. PubMed ID: 37133482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
    Nahm WJ; Shen J; Zito PM; Gonzalez AM; Nagrani N; Moore K; Badiavas EV; Kirsner RS; Nichols AJ
    J Drugs Dermatol; 2021 Mar; 20(3):260-267. PubMed ID: 33683072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
    Neugebauer R; Su KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
    J Am Acad Dermatol; 2019 Apr; 80(4):998-1005. PubMed ID: 30458208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
    Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
    Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
    Weinstock MA; Lee KC; Chren MM; Marcolivio K;
    J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
    Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
    JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.
    Quist SR; Gollnick HP
    Expert Opin Pharmacother; 2011 Feb; 12(3):451-61. PubMed ID: 21254950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
    Beatson M; Siegel JA; Chren MM; Weinstock MA
    Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma.
    Fayne R; Nanda S; Nichols A; Shen J
    J Drugs Dermatol; 2020 Feb; 19(2):202-204. PubMed ID: 32155018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
    Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
    Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
    Cheng B; Veerabagu S; Miller CJ; Sobanko JF; Shin TM; Higgins HW; Giordano CN; Etzkorn JR
    J Am Acad Dermatol; 2022 Sep; 87(3):592-596. PubMed ID: 35661760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
    Mohney L; Singh R; Grada A; Feldman S
    J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness.
    Emmerich VK; Cull D; Kelly KA; Feldman SR
    J Dermatolog Treat; 2022 Jun; 33(4):2075-2078. PubMed ID: 33947303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
    Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
    J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating keratinocyte carcinomas with a combination of imiquimod, 5-fluorouracil, and tretinoin using store-and-forward telemedicine in the age of coronavirus disease 2019 to promote social distancing.
    Nahm WJ; Badiavas EV; Kirsner RS; Nichols AJ; Harris ZC; Phillips AR; Shen J
    JAAD Case Rep; 2020 Sep; 6(9):931-934. PubMed ID: 32837989
    [No Abstract]   [Full Text] [Related]  

  • 17. A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis.
    Neugebauer R; Levandoski KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
    J Am Acad Dermatol; 2018 Apr; 78(4):710-716. PubMed ID: 29277731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for actinic keratoses.
    Gupta AK; Paquet M; Villanueva E; Brintnell W
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004415. PubMed ID: 23235610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
    Beatson M; Means AD; Leader NF; Robinson-Bostom L; Weinstock MA
    Acta Derm Venereol; 2019 Jun; 99(7):707-708. PubMed ID: 30896781
    [No Abstract]   [Full Text] [Related]  

  • 20. Rate and Proportion of Malignant Skin Biopsies for Basal Cell and Squamous Cell Carcinoma on the Face and Ears After a Single Course of Topical 5-Fluorouracil: The Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
    Means AD; Leader NF; Siegel JA; Arron ST; Walker JL; Pomerantz H; Beatson M; Weinstock MA
    Dermatol Surg; 2021 Apr; 47(4):541-543. PubMed ID: 33795573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.